Testicular Cancer Types: Seminoma, Nonseminoma, and More

A quick map of testicular cancer types

Most testicular cancers start in germ cells (the cells that make sperm). Germ cell tumors are usually
grouped into two big categories:
seminoma and nonseminoma. Then there are rarer “and more” types that don’t follow
the usual scriptlike sex cord-stromal tumors and testicular lymphoma.

The big categories you’ll hear most often

• Seminoma: Typically slower-growing and often very responsive to treatment.
• Nonseminoma (nonseminomatous germ cell tumors / NSGCT): Often faster-growing, more likely to be mixed,
  and may require more intensive treatment depending on stage and risk factors.
• Mixed germ cell tumors: Many tumors contain more than one subtype (sometimes seminoma + nonseminoma).
  In practice, mixed tumors are usually treated like nonseminoma.
• Rare non–germ cell tumors: Sex cord-stromal tumors (like Leydig and Sertoli cell tumors) and other
  uncommon cancers that can involve the testicle.

If this already feels like trying to sort a snack drawer full of mystery trail mix, you’re not alone.
Let’s break it down in plain Englishno pathology degree required.

Seminoma: the “classic” germ cell tumor

Seminoma is a germ cell tumor that tends to grow and spread more slowly than many nonseminomas. It’s also known for
being very treatable, even when it has spread beyond the testicle. Treatment usually starts the same way for most
suspected testicular cancers: removing the affected testicle (orchiectomy), which confirms the diagnosis
and often cures early-stage disease.

Why seminoma behaves differently

Seminoma cells often respond extremely well to therapies like radiation and chemotherapy. That responsiveness is one reason
outcomes are generally excellent. When doctors talk about “type matters,” this is part of what they mean: seminoma biology
can allow different (sometimes less intense) post-surgery strategies in certain stages.

Subtypes and related terms you might see

• “Pure seminoma” means the tumor is 100% seminoma under the microscope.
• Spermatocytic tumor (formerly “spermatocytic seminoma” in older language) is a distinct, rare tumor
  that typically occurs in older adults and behaves differently than classic seminoma. It’s not the usual case, but it
  sometimes appears in “and more” lists.

Practical takeaway: if the pathology report says “seminoma,” that’s generally reassuring from a treatment-response perspective.
But stage still matterstype isn’t the only piece of the puzzle.

Nonseminoma: faster-moving, often mixed, and full of subtypes

“Nonseminoma” isn’t one tumorit’s a category that includes several germ cell tumor subtypes. These tumors tend to occur
at younger ages than seminoma and may grow and spread more quickly. Many nonseminomas are mixed, meaning
they contain a combination of different subtype components.

The four major nonseminoma subtypes

1) Embryonal carcinoma

Embryonal carcinoma is often described as more aggressive. It can invade surrounding tissues and spread earlier through
lymphatic channels or blood. In mixed tumors, even a smaller embryonal component can influence how closely doctors watch
for recurrence and how they think about risk.

Example you might hear in clinic: “Because there’s embryonal carcinoma present and certain risk features, we’ll
talk about surveillance versus additional therapy after surgery.” Translation: they’re tailoring the plan to keep cure rates
high while avoiding unnecessary treatment when possible.

2) Yolk sac tumor (endodermal sinus tumor)

Yolk sac tumor is the most common testicular tumor in young children, but it can also appear as part of a mixed tumor in
adults. It’s often associated with elevated tumor markersespecially AFP (alpha-fetoprotein). Not every
tumor makes markers, but when AFP is high, it’s a clue that nonseminoma elements are involved.

3) Choriocarcinoma

Choriocarcinoma is rare but important because it can spread early through the bloodstream. It may be associated with high
hCG levels (human chorionic gonadotropin). Some people first learn about tumor markers because a lab result
looks like a pregnancy hormone in someone who is very much not pregnantwhich is both medically meaningful and objectively
weird.

4) Teratoma

Teratoma can be confusing because it may behave differently depending on context. In adults, teratoma found in a testicular
cancer setting is often treated as malignant behaviorally, even if parts look “mature.” Teratoma can also be relatively
resistant to chemotherapy compared with other germ cell components, which is why surgery plays a major role in certain
situations (especially for residual masses after chemotherapy).

Mixed germ cell tumors: the most common reality

In real life, many nonseminomas are mixed: embryonal + teratoma, yolk sac + embryonal, and so on. Sometimes a tumor contains
both seminoma and nonseminoma components. Clinically, if there’s any nonseminoma component (or certain marker patterns),
management often follows nonseminoma pathwaysbecause that’s the safest way to treat how the tumor is likely to behave.

“And more”: rarer tumors that can involve the testicle

Germ cell tumors dominate the conversation, but they’re not the whole story. A smaller group of tumors arise from the
supportive and hormone-producing tissues in the testicle, and other cancers can show up there too.

Sex cord-stromal tumors

These tumors come from cells involved in hormone production and structural support. They’re usually rarer than germ cell tumors,
and many are benignbut not all.

• Leydig cell tumors: Can produce hormones (like testosterone or estrogen). Some people develop symptoms
  such as breast tenderness/enlargement (gynecomastia) or changes in libido. In children, hormone effects can show up as early
  puberty signs.
• Sertoli cell tumors: Also rare; may be benign or malignant depending on features. They can sometimes be
  associated with hormonal symptoms as well.

Testicular lymphoma

Especially in older adults, a testicular mass isn’t always a germ cell tumor. Lymphoma can involve the
testicle and may require a completely different treatment approach. This is one reason age, imaging findings, pathology,
and overall clinical context matter.

Metastases and other rare cancers

In uncommon cases, cancers from elsewhere in the body can spread to the testicle. There are also extremely rare primary tumors
in and around testicular structures. The main point: if something is atypical, doctors don’t “guess”they confirm with imaging,
labs, and tissue diagnosis.

How doctors figure out the type

You can’t reliably tell seminoma vs nonseminoma by “how it feels.” (If you could, urologists would be out of a job, and the
internet would be even more chaotic than it already is.) Diagnosis usually includes several steps working together.

1) Physical exam + scrotal ultrasound

Ultrasound is the go-to imaging test for a testicular lump. It helps distinguish masses inside the testicle (more concerning)
from issues outside it (often benign, like cysts).

2) Blood tests: tumor markers

The most common markers are AFP, β-hCG, and LDH. Markers help with diagnosis,
staging, treatment planning, and follow-up. A key nuance: pure seminoma does not produce AFP. If AFP is elevated,
clinicians usually treat it as nonseminoma behavior, even if the microscope suggests seminoma.

3) Orchiectomy and pathology

For most suspected testicular cancers, removing the affected testicle is both diagnostic and therapeutic. The pathology report
identifies tumor type(s), whether it invaded blood/lymph vessels, and other features that help estimate recurrence risk.

4) Staging scans and risk assessment

Imaging such as CT scans can evaluate lymph nodes and other areas for spread. Type + stage + tumor marker levels + pathology features
guide whether someone is best served by surveillance, chemotherapy, radiation (in select situations), or additional surgery.

Why tumor type matters in real-world treatment

Here’s the practical “why should I care?”: type influences how likely a tumor is to spread, how it responds to different therapies,
and what follow-up looks like.

Seminoma treatment patterns

• Early stage: Orchiectomy may be followed by active surveillance or other options based on risk and preferences.
• More advanced stages: Often treated effectively with chemotherapy, and sometimes radiation depending on the scenario.

Nonseminoma treatment patterns

• Early stage: Orchiectomy plus either surveillance or additional therapy depending on risk features.
• Higher stage: Frequently involves chemotherapy, and sometimes surgery afterward (for example, to remove remaining tissue).

Another big reason type matters is long-term planning: some treatments carry different late-effect risks, and the goal is always
the samecure the cancer while minimizing collateral damage.

Symptoms worth taking seriously (yes, even if you’re busy)

Testicular cancer often shows up as a painless lump or swelling in one testicle. It can also feel like heaviness
in the scrotum, a dull ache in the groin/lower abdomen, or a change in how a testicle feels. Pain can happen toodon’t let
“it doesn’t hurt” be your only filter.

If you find a new lump, don’t panicbut don’t procrastinate. Your body doesn’t send push notifications; it sends physical clues.
Getting an exam and ultrasound is the medical version of clicking “Check for updates.”

FAQ: quick answers people actually ask

Can a tumor be both seminoma and nonseminoma?

Yes. Mixed germ cell tumors are common. If there’s a nonseminoma component, treatment often follows nonseminoma strategies because
that component can drive behavior and risk.

Do tumor markers always rise?

No. Some tumors don’t produce markers, and marker levels can vary by subtype and stage. That’s why doctors use a combination of
ultrasound, surgery/pathology, markers, and imaging.

Is seminoma “better” than nonseminoma?

“Better” isn’t a perfect word, but seminoma often grows more slowly and responds very well to treatment. Nonseminomas can be more
aggressive, but cure rates are still highespecially with timely, appropriate therapy.

Does removing a testicle affect fertility or hormones?

Many people maintain normal testosterone and fertility with one healthy testicle, but it depends on individual factors.
Sperm banking may be recommended before certain treatments, especially chemotherapy.

Wrapping it up: what to remember

If you remember only three things, make them these:

1. Type matters: seminoma and nonseminoma behave differently, and subtypes (often mixed) help shape treatment.
2. Diagnosis is a team effort: ultrasound, tumor markers, surgery/pathology, and scans each contribute important clues.
3. Most cases are highly treatable: early evaluation and proper management are the power combo.

And if you found a lump: get it checked. The best time to deal with a problem is before it has time to get creative.

Experiences that often come with the journey (real talk, no sugarcoating)

When people talk about testicular cancer, they usually start with facts: “It’s curable,” “It’s common in younger men,”
“Look for a lump.” All true. But the lived experience can feel like a fast-moving series of emotional tabs opening in your
brainfear, confusion, relief, awkward humor, and about 47 questions you didn’t know you had.

A common story begins with something small: a lump noticed in the shower, a testicle that feels heavier, or a vague ache that
doesn’t quit. Many people describe the same internal debate: “Is this real, or am I overthinking?” (Spoiler: if you’re checking
the same spot three days in a row, it’s worth a professional look.) The first appointment can be surprisingly quick: exam,
ultrasound, and suddenly the situation feels more official than you wanted.

Then comes the vocabulary. “Seminoma.” “Nonseminoma.” “Tumor markers.” People often say it feels like learning a new language
while riding a roller coaster. The blood tests can be emotionally loadedwatching AFP or hCG numbers can feel like tracking
a scoreboard you never asked to play on. Some find comfort in the structure (“We have a plan. We have data.”), while others
find it stressful (“Why is my life now a chart?”). Both reactions are normal.

Treatment brings its own set of experiences. Orchiectomy can come with practical concerns people don’t always talk about out loud:
body image, dating anxiety, and “How do I even explain this to someone without turning the mood into a medical podcast?”
Many people report that it helps to remember the goal: cure first, details second. Some choose a testicular prosthesis; others
don’t. There’s no single “right” choicejust what feels right for you.

If chemotherapy is needed, the experience can vary widely. Some people feel fatigued and foggy; others are surprised they can
still do parts of normal life between cycles. Support often becomes a skill: accepting help, letting friends drive you, or
allowing someone else to do the grocery run without you micromanaging the banana selection. And fertility discussions can feel
unexpectedly emotional. Even people who weren’t planning children “right now” sometimes feel a gut punch hearing the words
“sperm banking.” It’s not just logisticsit’s identity, future plans, and control.

After treatment, the follow-up phase can be its own journey. Surveillance appointments can trigger “scanxiety,” even when
everything is going well. Many survivors say the fear fades with time, especially when they learn what’s normal for their body
and what deserves attention. People also often find meaning in small habits: self-exams, keeping follow-up schedules, and
talking openly with friends or family so someone else isn’t alone in their own moment of uncertainty someday.

The emotional headline most people eventually land on is this: testicular cancer can be scary, but it’s also a situation where
modern medicine has a strong track record. Getting checked early, understanding your type, and following the plan can turn a
frightening discovery into a story that ends with the words you actually want to hear“You’re cancer-free.”